RespireRx Pharmaceuticals COO Mark Varney receives $1.4M in 2006
RespireRx Pharmaceuticals reports 2006 executive compensation
By ExecPay News
Published: April 5, 2007
RespireRx Pharmaceuticals reported fiscal year 2006 executive compensation information on April 5, 2007.
In 2006, six executives at RespireRx Pharmaceuticals received on average a compensation package of $698K.
Average pay of disclosed executives at RespireRx Pharmaceuticals
Mark A. Varney, Chief Operating Officer, received $1.4M in total. 64% of Varney's compensation, or $886K, was in option awards. Varney also received $277K in salary and $223K in other compensation.
Roger G. Stoll, Chief Executive Officer, received a compensation package of $1.1M. 39% of the compensation package, or $416K, was in option awards.
Harry H. Mansbach, Chief Medical Officer, earned $607K in 2006.
James H. Coleman, Senior Vice President, Business Development, received $394K in 2006.
Gary A. Rogers, Senior Vice President, Pharmaceutical Research, earned $376K in 2006.
Maria S. Messinger, Chief Financial Officer, received $361K in 2006.
Related executives
Roger Stoll
RespireRx Pharmaceuticals
Chairman
Maria Messinger
RespireRx Pharmaceuticals
Chief Financial Officer
James Coleman
RespireRx Pharmaceuticals
Senior Vice President, Business Development
Harry Mansbach
RespireRx Pharmaceuticals
Chief Medical Officer
Gary Rogers
RespireRx Pharmaceuticals
Senior Vice President, Pharmaceutical Research
Mark Varney
RespireRx Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 5, 2007.